Golden Biotechnology Corporation
TWO: 4132.TWO0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- Taipei Exchange
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- CEO
- Sheng Yong Liu
- Employees
- 110
- Headquarters
- New Taipei City, Taiwan
- IPO year
- 2012
- Market cap
- NT$632.3M
- Website
- https://www.goldenbiotech.com/en
Loading 4132…
Loading profile data…Frequently asked questions about 4132
What does Golden Biotechnology Corporation (4132.TWO) do?
Golden Biotechnology Corporation operates as a drug discovery and healthy food supplement manufacturing company in Taiwan, the United States, Japan, China, Korea, and Singapore. Its products include Liverty that is used for liver health support and fatigue; Rasle, an auto-immune adjuvant therapy; ZSAINO, a nourishment product for recovery from i...
Where does 4132.TWO trade?
Golden Biotechnology Corporation (4132.TWO) trades on the Taipei Exchange.
What sector is 4132.TWO in?
Golden Biotechnology Corporation (4132.TWO) operates in the Healthcare sector, specifically in the Drug Manufacturers - Specialty & Generic industry.
Who is the CEO of Golden Biotechnology Corporation?
Sheng Yong Liu is the chief executive officer of Golden Biotechnology Corporation (4132.TWO).
Where is Golden Biotechnology Corporation headquartered?
Golden Biotechnology Corporation is headquartered in Taiwan.
Does 4132.TWO pay a dividend?
Golden Biotechnology Corporation (4132.TWO) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did 4132.TWO go public?
Golden Biotechnology Corporation (4132.TWO) completed its initial public offering in 2012.